1. Home
  2. MGYR vs RCEL Comparison

MGYR vs RCEL Comparison

Compare MGYR & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

N/A

Current Price

$17.49

Market Cap

116.3M

Sector

Finance

ML Signal

N/A

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$5.08

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGYR
RCEL
Founded
1922
N/A
Country
United States
United States
Employees
N/A
226
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.3M
126.8M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MGYR
RCEL
Price
$17.49
$5.08
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.88
AVG Volume (30 Days)
3.2K
358.7K
Earning Date
04-23-2026
05-14-2026
Dividend Yield
2.30%
N/A
EPS Growth
26.83
N/A
EPS
0.98
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$17.17
Revenue Next Year
N/A
$49.82
P/E Ratio
$17.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.03
$3.22
52 Week High
$20.00
$7.12

Technical Indicators

Market Signals
Indicator
MGYR
RCEL
Relative Strength Index (RSI) 52.27 61.76
Support Level $16.80 $3.55
Resistance Level $17.69 $5.32
Average True Range (ATR) 0.23 0.45
MACD -0.01 0.08
Stochastic Oscillator 59.21 65.18

Price Performance

Historical Comparison
MGYR
RCEL

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: